Kendra Adams joined C4 Therapeutics in November 2020 as our Senior Vice President of Communications and Investor Relations. Previously, Kendra served as Vice President, External Communications and Investor Relations at Agios Pharmaceuticals, Inc. where she was responsible for corporate communication strategy for two precision medicine oncology launches. Kendra has more than 15 years of communications and investor relations experience in the biotechnology sector, previously serving Investor Relations roles of increasing responsibility at ARIAD Pharmaceuticals and Amgen. Earlier in her career, Kendra held a variety of finance and operational roles at KPMG LLP and General Electric Company. Kendra holds a B.A. in Economics from Hamilton College.